Posts tagged ‘ASCO Conference Coverage’
The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) takes place in Chicago in just over two weeks time from June 1 – 5. The ASCO abstracts will be publicly available tomorrow (May 16) at 6pm EDT.
We’re looking forward to being at ASCO, and picking up the latest data for new products and evaluating the impact this may have on our understanding of key pathways and drug development targets.
If you want to know what Sally Church, PhD predicts will be highlights of the ASCO 2012 meeting (in the absence of any abstract information) then watch her informative video and check out her ASCO preview post on Pharma Strategy Blog.
If you plan to be at ASCO 2012 and would like to meet up and discuss our capabilities, please contact us.
Sally Church on Pharma Strategy Blog is aggregating the tweets from the 2011 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Twitter hashtag #ASCO11.
If you are unable to attend, you can follow what’s happening on Pharma Strategy Blog.
In Sally’s video preview of ASCO 2011, she talks about ovarian cancer, metastatic melanoma and soft tissue sarcoma. The video is well worth watching. We especially like the 20 second animated intro sequence! Sally will be writing from ASCO on Pharma Strategy Blog and on twitter as @MaverickNY.
Pieter Droppert has also published an ASCO preview on Biotech Strategy Blog focused on prostate cancer. He is excited about data that will be presented on the use of circulating tumor cells (CTC) as a biomarker. Pieter will be tweeting from ASCO as @3NT.
If you are attending ASCO we look forward to meeting you at what is set to be an exciting conference, otherwise do follow the action on Pharma Strategy Blog.